Ledger.Open graph →
SEC Form D · filed August 25, 2023

Taysha Gene Therapies, Inc

Offering
$150.0M
Sold
$150.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Sean P. Stalfort · Dallas, TXDirectorKathleen P. Reape · Dallas, TXDirectorSean P. Nolan · Morrisville, NCExec · DirectorPhillip P. Donenberg · Dallas, TXDirectorKamran P. Alam · Dallas, TXExecSean P. Nolan · Morrisville, NCExec · DirectorKathleen P. Reape · Dallas, TXDirectorKamran P. Alam · Dallas, TXExecSukumar P. Nagendran · Dallas, TXExec · DirectorLaura P. Sepp-Lorenzino · Dallas, TXDirectorSukumar P. Nagendran · Dallas, TXExec · DirectorPhillip P. Donenberg · Dallas, TXDirectorLaura P. Sepp-Lorenzino · Dallas, TXDirectorSean P. Stalfort · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗